0
No votes yet
Oncology Essentials

Diagnosis, Treatment, and Management of Immune Thrombocytopenia

Debra Winkeljohn
CJON 2013, 17(6), 664-666 DOI: 10.1188/13.CJON.664-666

Management of immune thrombocytopenia (ITP) requires accurate assessment and evaluation, appropriate treatment strategies, and timely nursing interventions (e.g., monitoring, bleeding prevention, patient education). The overview of ITP in the current article reviews its etiology and provides updates about medical management and key components of nursing care.

References 

Amgen Inc. (2008). <i>Nplate® (romiplostim)</i> [Package insert]. Thousand Oaks, CA: Author.

George, J. N. (2013). Treatment and prognosis of immune thrombocytopenia in adults. Retrieved from <a target="_blank" href='http://bit.ly/1a7GPKn'>http://bit.ly/1a7GPKn</a>

GlaxoSmithKline. (2008). <i>Promacta® (eltrombopag)</i> [Package insert]. Research Triangle Park, NC: Author.

Neunert, C., Lim, W., Crowther, M., Cohen, A., Solberg, L., Jr., & Crowther, M. A. (2011). The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. <i>Blood, 117</i>, 4190-4207. doi:10.1182/blood-2010-08-302984

Provan, D., Stasi, R., Newland, A. C., Blanchette, V. S., Bolton-Maggs, P., Bussel, J. B., … Kuter, D. J. (2010). International consensus report on the investigation and management of primary immune thrombocytopenia. <i>Blood, 115</i>, 168-186. doi:10.1182/blood-2009-06-225565

Shelton, B. K. (2009). Myelosuppression. In B. Holmes Gobel, S. Triest-Robertson, & W. H. Vogel (Eds.), <i>Advanced oncology nursing certification: Review and resource manual</i> (pp. 405-442). Pittsburgh, PA: Oncology Nursing Society.